Richard Mulligan

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Seattle, WA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Aaron M. Grossman, Attorney-in-Fact for Richard Mulligan
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Richard Mulligan

Form 4 holding Director

Sana Biotechnology, Inc.

Security class
Common Stock
Shares / value
2,698,121
Estimated value
$10,489,755
Report date
25 Sep 2024
Price
$3.89
Ownership
Direct
Form 4 holding Director

BIOGEN INC.

Security class
Common Stock
Shares / value
15,099
Estimated value
$3,744,552
Report date
15 Jun 2022
Price
$248.00
Ownership
Direct
Form 4 holding Director

Bausch Health Companies Inc.

Security class
Common Shares, No Par Value
Shares / value
101,269
Estimated value
$1,074,464
Report date
17 May 2024
Price
$10.61
Ownership
Direct

Insider Reports Filed by Richard Mulligan

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .